Global and China Drugs for Vulvovaginal Candidiasis Market Research by Company, Type & Application 2013-2025

Publisher Name :
Date: 15-Jun-2018
No. of pages: 81

Summary

Market Segment as follows:

By Type

- Miconazole

- Clotrimazole

- Fluconazole

- Econazole

- Other

By Application

- Hospital & Clinic

- Pharmacy

By Company

- Bayer

- Perrigo

- J & J

- Pfizer

- Bristol-Myers Squibb

- Effik

- Teva

- Sanofi

- Cisen Pharmaceutical

- Kingyork Group

The main contents of the report including:

Section 1: Product definition, type and application, global and China market overview;

Section 2: Global and China Market competition by company;

Section 3: Global and China sales revenue, volume and price by type;

Section 4: Global and China sales revenue, volume and price by application;

Section 5: China export and import;

Section 6: Company information, business overview, sales data and product specifications;

Section 7: Industry chain and raw materials;

Section 8: SWOT and Porter's Five Forces;

Section 9: Conclusion.

Global and China Drugs for Vulvovaginal Candidiasis Market Research by Company, Type & Application 2013-2025

Table of Contents

1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Miconazole
1.1.2.2 Clotrimazole
1.1.2.3 Fluconazole
1.1.2.4 Econazole
1.1.2.5 Other
1.1.3 Market by Application
1.1.3.1 Hospital & Clinic
1.1.3.2 Pharmacy
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and Regional Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and Regional Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and Regional Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 Regional Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Bayer
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Perrigo
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 J & J
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Pfizer
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Bristol-Myers Squibb
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Effik
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Teva
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Sanofi
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Cisen Pharmaceutical
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Kingyork Group
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion

List of Tables

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table China Market Sales Revenue by Company 2013-2017
Table China Market Sales Revenue Share by Company 2013-2017
Table China Market Sales Volume by Company 2013-2017
Table China Market Sales Volume Share by Company 2013-2017
Table China Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table China Market Sales Revenue by Type 2013-2017
Table China Market Sales Revenue Share by Type 2013-2017
Table China Market Sales Volume by Type 2013-2017
Table China Market Sales Volume Share by Type 2013-2017
Table China Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table China Market Sales Revenue by Application 2013-2017
Table China Market Sales Revenue Share by Application 2013-2017
Table China Market Sales Volume by Application 2013-2017
Table China Market Sales Volume Share by Application 2013-2017
Table China Price by Application 2013-2017
Table China Export 2013-2017 (Million USD)
Table China Export 2013-2017 (Volume)
Table China Import 2013-2017 (Million USD)
Table China Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer
Table Sales Revenue, Volume, Price, Cost and Margin of Perrigo
Table Sales Revenue, Volume, Price, Cost and Margin of J & J
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Table Sales Revenue, Volume, Price, Cost and Margin of Effik
Table Sales Revenue, Volume, Price, Cost and Margin of Teva
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Table Sales Revenue, Volume, Price, Cost and Margin of Cisen Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Kingyork Group

List of Figures

Figure Miconazole Market Size and CAGR 2013-2017 (Million USD)
Figure Miconazole Market Size and CAGR 2013-2017 (Volume)
Figure Miconazole Market Forecast and CAGR 2018-2025 (Million USD)
Figure Miconazole Market Forecast and CAGR 2018-2025 (Volume)
Figure Clotrimazole Market Size and CAGR 2013-2017 (Million USD)
Figure Clotrimazole Market Size and CAGR 2013-2017 (Volume)
Figure Clotrimazole Market Forecast and CAGR 2018-2025 (Million USD)
Figure Clotrimazole Market Forecast and CAGR 2018-2025 (Volume)
Figure Fluconazole Market Size and CAGR 2013-2017 (Million USD)
Figure Fluconazole Market Size and CAGR 2013-2017 (Volume)
Figure Fluconazole Market Forecast and CAGR 2018-2025 (Million USD)
Figure Fluconazole Market Forecast and CAGR 2018-2025 (Volume)
Figure Econazole Market Size and CAGR 2013-2017 (Million USD)
Figure Econazole Market Size and CAGR 2013-2017 (Volume)
Figure Econazole Market Forecast and CAGR 2018-2025 (Million USD)
Figure Econazole Market Forecast and CAGR 2018-2025 (Volume)
Figure Other Market Size and CAGR 2013-2017 (Million USD)
Figure Other Market Size and CAGR 2013-2017 (Volume)
Figure Other Market Forecast and CAGR 2018-2025 (Million USD)
Figure Other Market Forecast and CAGR 2018-2025 (Volume)
Figure Hospital & Clinic Market Size and CAGR 2013-2017 (Million USD)
Figure Hospital & Clinic Market Size and CAGR 2013-2017 (Volume)
Figure Hospital & Clinic Market Forecast and CAGR 2018-2025 (Million USD)
Figure Hospital & Clinic Market Forecast and CAGR 2018-2025 (Volume)
Figure Pharmacy Market Size and CAGR 2013-2017 (Million USD)
Figure Pharmacy Market Size and CAGR 2013-2017 (Volume)
Figure Pharmacy Market Forecast and CAGR 2018-2025 (Million USD)
Figure Pharmacy Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Drugs for Vulvovaginal Candidiasis Market Size and CAGR 2013-2017 (Million USD)
Figure Global Drugs for Vulvovaginal Candidiasis Market Size and CAGR 2013-2017 (Volume)
Figure Global Drugs for Vulvovaginal Candidiasis Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Drugs for Vulvovaginal Candidiasis Market Forecast and CAGR 2018-2025 (Volume)
Figure China Drugs for Vulvovaginal Candidiasis Market Size and CAGR 2013-2017 (Million USD)
Figure China Drugs for Vulvovaginal Candidiasis Market Size and CAGR 2013-2017 (Volume)
Figure China Drugs for Vulvovaginal Candidiasis Market Forecast and CAGR 2018-2025 (Million USD)
Figure China Drugs for Vulvovaginal Candidiasis Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Drugs for Vulvovaginal Candidiasis SWOT List
Figure Healthcare & Medical Porter's Five Forces
  • 2018-2023 India Bacterial Vaginosis Drug Market Report (Status and Outlook)
    Published: 16-Aug-2018        Price: US 3360 Onwards        Pages: 84
    In 2017, the Bacterial Vaginosis Drug market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the top players include - Pfizer - Teva - Perrigo - Mylan - Lupin Pharmaceuticals - Prasco - West-Ward - Edenvridge Split by product types/category, covering - Clindamycin - Metronidazole - Tinidazole - Other......
  • Global and India Postmenopausal Vaginal Atrophy Treatment Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2018        Price: US 2000 Onwards        Pages: 105
    Summary Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase. Market Segment as follows: By Type - Creams - Tablets - Patches......
  • 2018-2023 Philippines Bacterial Vaginosis Drug Market Report (Status and Outlook)
    Published: 16-Aug-2018        Price: US 3360 Onwards        Pages: 84
    In 2017, the Bacterial Vaginosis Drug market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Philippines market, the top players include - Pfizer - Teva - Perrigo - Mylan - Lupin Pharmaceuticals - Prasco - West-Ward - Edenvridge Split by product types/category, covering - Clindamycin - Metronidazole - Tinidazole......
  • 2018-2023 UK Bacterial Vaginosis Drug Market Report (Status and Outlook)
    Published: 16-Aug-2018        Price: US 3360 Onwards        Pages: 84
    In 2017, the Bacterial Vaginosis Drug market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In UK market, the top players include - Pfizer - Teva - Perrigo - Mylan - Lupin Pharmaceuticals - Prasco - West-Ward - Edenvridge Split by product types/category, covering - Clindamycin - Metronidazole - Tinidazole - Other ......
  • 2018-2023 United States Bacterial Vaginosis Drug Market Report (Status and Outlook)
    Published: 16-Aug-2018        Price: US 3360 Onwards        Pages: 84
    In 2017, the Bacterial Vaginosis Drug market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the top players include - Pfizer - Teva - Perrigo - Mylan - Lupin Pharmaceuticals - Prasco - West-Ward - Edenvridge Split by product types/category, covering - Clindamycin - Metronidazole - Tinidazole......
  • Vulvovaginal Candidiasis - Market Insights, Epidemiology and Market Forecast - 2027
    Published: 03-Aug-2018        Price: US 6250 Onwards        Pages: 120
    DelveInsight's ‘Vulvovaginal Candidiasis - Market Insights, Epidemiology and Market Forecast-2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Vulvovaginal Candidiasis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size......
  • Global Drugs for Vulvovaginal Candidiasis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 02-Aug-2018        Price: US 3480 Onwards        Pages: 131
    The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Drugs for Vulvovaginal Candidiasis Market 2018, Forecast to 2023
    Published: 02-Aug-2018        Price: US 4880 Onwards        Pages: 136
    The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after ......
  • 2018-2023 Global Drugs for Vulvovaginal Candidiasis Consumption Market Report
    Published: 02-Aug-2018        Price: US 4660 Onwards        Pages: 131
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Drugs for Vulvovaginal Candidiasis market for 2018-2023. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs